Search


PDF Archive search engine
Last database update: 17 May at 11:24 - Around 76000 files indexed.


Show results per page

Results for «myeloid»:


Total: 15 results - 0.021 seconds

Jurjen-Versluis 100%

Allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia a personalized approach Jurjen Versluis Allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia a personalized approach Jurjen Versluis Allogeneic Hematopoietic Stem Cell Transplantation in patients with Acute Myeloid Leukemia a personalized approach Copyright © 2017 Jurjen Versluis, Rotterdam, The Netherlands.

https://www.pdf-archive.com/2018/03/12/jurjen-versluis/

12/03/2018 www.pdf-archive.com

ER1120 87%

Mario Cazzola (Pavia) 15:15-15:40 15:40-15:45 Update of the WHO classification of myeloid malignancies Mario Cazzola (Pavia) Discussion 15:45-16:10 16:10-16:15 Update of the WHO classification of lymphoid malignancies Steven Swcrdlow (Pittsburgh) Discussion 16:15-16:45 Round table/general discussion 16:45-17:15 Coffee Break 1 SESSION II Biologically-Based Acute Myeloid Leukaemia (AML) Therapy Chair:

https://www.pdf-archive.com/2018/10/10/er1120/

10/10/2018 www.pdf-archive.com

Dr-Griesinger Veroeffentlichungen 70%

German Acute Myeloid Leukaemia Cooperative Group;

https://www.pdf-archive.com/2016/08/25/dr-griesinger-veroeffentlichungen/

25/08/2016 www.pdf-archive.com

cadbf3312136057a531b5a6a6435c2f1 (1) 67%

One Physician’s Experience Caring for His Wife with Cancer 1:30pm 1:45pm Break/Exhibitor Session 1:45pm 3:00pm Concurrent Breakout Sessions Non-Hodgkin Lymphoma (NHL)—Low Grade Chronic Myeloid Leukemia (CML) Acute Leukemias (ALL/AML) Myeloproliferative Neoplasms (MPN) Living Well Though the Seasons of Survivorship Exploring Cancer Clinical Trials 3:00pm Ashkan Emadi, MD University of Maryland Marlene &

https://www.pdf-archive.com/2018/07/13/cadbf3312136057a531b5a6a6435c2f1-1/

13/07/2018 www.pdf-archive.com

Grannys%20List%20I-Z 66%

(full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed Do cannabinoids have a therapeutic role in transplantation (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923447/?tool=pubmed Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties (full – 2010) http://onlinelibrary.wiley.com/doi/10.1002/eji.201040667/full Cannabinoids and Viral Infections (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903762/?tool=pmcentrez Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity.

https://www.pdf-archive.com/2013/06/13/grannys-20list-20i-z/

13/06/2013 www.pdf-archive.com

elisa-kits-for-Immunology 60%

Focus on lab research Service for life science www.elabscience.com 1 Innate Immunity Cat.No Cat.No Product Name Product Name Detection Range Detection Range Sensitivity Sensitivity Test Method E-EL-H0020 Human MCP-1 (Monocyte Chemotactic Protein 1) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0024 Human MCP-3 (Monocyte Chemotactic Protein 3) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0025 Human ECF/CCL11 (Eosinophil Chemotactic Factor) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0032 Human CTACK (Cutaneous T-cell Attracting Chemokine) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0036 Human sCD163 (Soluable Cluster of Differentiation 163) ELISA Kit 1.56--100ng/mL 0.94ng/mL Sandwich E-EL-H0041 Human CFD (Complement Factor D) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0043 Human CRP (C-Reactive Protein) ELISA Kit 0.78--50ng/mL 0.47ng/mL Sandwich E-EL-H0044 Human CX3CL1 (Chemokine C-X3-C-Motif Ligand 1) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0045 Human GROα/CXCL1 (Growth Regulated Oncogene Alpha) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0046 Human ENA-78 (Epithelial Neutrophil Activating Peptide 78) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0047 Human GCP-2 (Granulocyte Chemotactic Protein 2) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0050 Human IP-10/CXCL10 (Interferon Gamma Induced Protein 10kDa) ELISA Kit 7.81--500pg/mL 4.69pg/mL Sandwich E-EL-H0051 Human I-TAC (Interferon Inducible T-cell Alpha Chemoattractant) 62.5--4000pg/mL ELISA Kit 37.5pg/mL Sandwich E-EL-H0052 Human SDF-1 (Stromal Cell Derived Factor 1) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0053 Human BLC (B-Lymphocyte Chemoattractant) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0085 Human IFN-β (Interferon Beta) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0088 Human IL-1α (Interleukin 1 Alpha) ELISA Kit 3.91--250pg/mL 2.34pg/mL Sandwich E-EL-H0089 Human IL-1ra/IL-1F3 (Interleukin 1 Receptor Antagonist) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0099 Human IL-2 (Interleukin 2) ELISA Kit 125--8000pg/mL 75pg/mL Sandwich E-EL-H0100 Human IL-3 (Interleukin 3) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0102 Human IL-6 (Interleukin 6) ELISA Kit 7.81--500pg/mL 4.69pg/mL Sandwich E-EL-H0104 Human IL-13(Interleukin 13)ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0105 Human IL-17 (Interleukin 17) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0106 Human IL-22 (Interleukin 22) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0107 Human IL-23 (Interleukin 23) ELISA Kit 39.06--2500pg/mL 23.44pg/mL Sandwich E-EL-H0108 Human IFN-γ (Interferon Gamma) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0109 Human TNF-α (Tumor Necrosis Factor Alpha) ELISA Kit 7.81--500 pg/mL 4.69 pg/mL Sandwich E-EL-H0116 Human LH (Luteinizing Hormone) ELISA Kit 0.94--60mIU/mL 0.56mIU/mL Sandwich E-EL-H0149 Human IL-1β (Interleukin 1 Beta) ELISA Kit 7.81--500pg/mL 4.69pg/mL Sandwich E-EL-H0150 Human IL-12 (Interleukin 12) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich 2 www.elabscience.com Focus on lab research Service for life science Cat.No Cat.No Product Name Product Name Detection DetectionRange Range Sensitivity Sensitivity Test Method E-EL-H0167 Human C4 (Complement Component 4) ELISA Kit 4.69--300ng/mL 2.81ng/mL Sandwich E-EL-H0180 Human IL-9 (Interleukin 9) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0189 Human C4a (Complement Component 4a) ELISA Kit 1.56--100ng/mL 0.94ng/mL Sandwich E-EL-H0190 Human C5a (Complement Component 5a) ELISA Kit 78.13--5000pg/mL 46.88pg/mL Sandwich E-EL-H0191 Human IL-5 (Interleukin 5) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0192 Human IL-6R (Interleukin 6 Receptor) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0216 Human IL-32(Interleukin 32)ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0222 Human IL-15 (Interleukin 15) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0235 Human IL-16 (Interleukin 16) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0253 Human IL-18 (Interleukin 18) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0254 Human IL-19 (Interleukin 19) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0279 Human IL-20 (Interleukin 20) ELISA Kit 62.5--4000pg/mL 37.5pg/mL Sandwich E-EL-H0386 Human FETUA (Fetuin A) ELISA Kit 9.38--600ng/mL 5.63ng/mL Sandwich E-EL-H0424 Human IL10Rβ (Interleukin 10 Receptor Beta) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0486 Human ITIH4 (Inter Alpha-Globulin Inhibitor H4) ELISA Kit 3.13--200ng/mL 1.88ng/mL Sandwich E-EL-H0586 Human BMP-10 (Bone Morphogenetic Protein 10) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0600 Human BRAK/CXCL14 (Breast and Kidney Expressed Chemokine) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0609 Human C1q-Ab (Anti-Complement 1q Antibody) ELISA Kit 1.56--100ng/mL 0.94ng/mL Sandwich E-EL-H0648 Human IL-7 (Interleukin 7) ELISA Kit 7.81--500pg/mL 4.69pg/mL Sandwich E-EL-H0651 Human CT-1 (Cardiotrophin 1) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0671 Human CTSL (Cathepsin L) ELISA Kit 62.5--4000pg/mL 37.5pg/mL Sandwich E-EL-H0699 Human CCL1 (Chemokine C-C-Motif Ligand 1) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H0702 Human CCL3L1 (Chemokine C-C-Motif Ligand 3 Like Protein 1) ELISA Kit 78.13--5000pg/mL 46.88pg/mL Sandwich E-EL-H0703 Human CCL4L1 (Chemokine C-C-Motif Ligand 4 Like Protein 1) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0707 Human CX3CR1 (Chemokine C-X3-C-Motif Receptor 1) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H0803 Human C1q (Complement 1q) ELISA Kit 78.13--5000pg/mL 46.88pg/mL Sandwich E-EL-H0804 Human C3 (Complement Component 3) ELISA Kit 7.81--500ng/mL 4.69ng/mL Sandwich E-EL-H0806 Human C7 (Complement Component 7) ELISA Kit 12.5--800pg/mL 7.5pg/mL Sandwich E-EL-H0808 Human C1r (Complement Component 1R) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0809 Human C2 (Complement Component 2) ELISA Kit 0.63--40ng/mL 0.38ng/mL Sandwich E-EL-H0810 Human C5 (Complement Component 5) ELISA Kit 78.13--5000pg/mL 46.88pg/mL Sandwich E-EL-H0811 Human C8b (Complement Component 8b) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0812 Human C8g (Complement Component 8g) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich Focus on lab research Service for life science www.elabscience.com 3 Cat.No Cat.No Product Name Product Name Detection Range Detection Range Sensitivity Sensitivity Test Method E-EL-H0813 Human C9 (Complement Component 9) ELISA Kit 0.47--30ng/mL 0.28ng/mL Sandwich E-EL-H0814 Human CFB (Complement Factor B) ELISA Kit 3.13--200ng/mL 1.88ng/mL Sandwich E-EL-H0815 Human CFH (Complement Factor H) ELISA Kit 23.44--1500ng/mL 14.06ng/mL Sandwich E-EL-H0816 Human CFI (Complement Factor I) ELISA Kit 2.34--150ng/mL 1.41ng/mL Sandwich E-EL-H0817 Human CFP (Complement Factor P) ELISA Kit 1.56--100ng/mL 0.94ng/mL Sandwich E-EL-H0818 Human C3a (Complement Component 3a) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0819 Human C3bR (Complement Fragment 3b Receptor) ELISA Kit 0.63--40ng/mL 0.38ng/mL Sandwich E-EL-H0820 Human C3b (Complement Fragment 3b) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0821 Human C3c (Complement Fragment 3c) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0823 Human C4b (Complement Component 4b) ELISA Kit 4.69--300ng/mL 2.81ng/mL Sandwich E-EL-H0824 Human C5c (Complement C5 Convertase) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0825 Human C5b (Complement Fragment 5b) ELISA Kit 0.78--50ng/mL 0.47ng/mL Sandwich E-EL-H0853 Human CXCR1 (CXC-Chemokine Receptor 1) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0854 Human CXCR3 (Chemokine CXC Receptor 3) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0951 Human TLR2 (Toll-Like Receptor 2) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H0952 Human TLR9 (Toll-Like Receptor 9) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H0961 Human C3c (Complement C3 Convertase) ELISA Kit 0.63--40ng/mL 0.38ng/mL Sandwich E-EL-H1007 Human β-TG (β-Thromboglobulin) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich E-EL-H1009 Human MIγ/CXCL9 (Monocyte Interferon Gamma Inducing Factor) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H1028 Human IL1R1 (Interleukin 1 Receptor Type I) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H1031 Human IL-2Rβ (Interleukin 2 Receptor Beta) ELISA Kit 78.13--5000pg/mL 46.88pg/mL Sandwich E-EL-H1032 Human NFIL3 (Nuclear Factor, Interleukin 3 Regulated ) ELISA Kit 0.5--10ng/mL 0.1ng/mL Sandwich E-EL-H1158 Human MCP-2/CCL8 (Monocyte Chemotactic Protein 2) ELISA Kit 6.25--400pg/mL 3.75pg/mL Sandwich E-EL-H1159 Human MCP-4/CCL13 (Monocyte Chemotactic Protein 4) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H1192 Human PTK (Protein Tyrosine Kinase) ELISA Kit 1.56--100ng/mL 0.94ng/mL Sandwich E-EL-H1270 Human PARC/CCL18 (Pulmonary Activation Regulated Chemokine) ELISA Kit 78.13--5000pg/mL 46.88pg/mL Sandwich E-EL-H1348 Human MPIF-1/CCL23 (Myeloid Progenitor Inhibitory Factor 1) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H1387 Human RANκL (Receptor Activator of Nuclear Factor Kappa B Ligand) ELISA Kit 0.16--10ng/mL 0.09ng/mL Sandwich E-EL-H1528 Human MIP-3β/ELC/CCL19 (Macrophage Inflammatory Protein 3β) ELISA Kit 15.63--1000pg/mL 9.38pg/mL Sandwich E-EL-H1539 Human TLR4 (Toll-Like Receptor 4) ELISA Kit 0.31--20ng/mL 0.19ng/mL Sandwich E-EL-H1592 Human IL7R (Interleukin 7 Receptor) ELISA Kit 1.56--100ng/mL 0.94ng/mL Sandwich E-EL-H1596 Human sTREM-1 (soluble Triggering Receptor Expressed on Myeloid Cells-1) ELISA Kit 31.25--2000pg/mL 18.75pg/mL Sandwich 4 www.elabscience.com Focus on lab research Service for life science

https://www.pdf-archive.com/2016/08/11/elisa-kits-for-immunology/

11/08/2016 www.pdf-archive.com

Kraeftpakker-Oversigt-over-foloebsledere-og-koordinatorer 58%

Lymfekræft Myelomatose Akut leukæmi Kronisk myeloid sygdom Kræft i nyre- og blære, Kræft i prostata, penis og testikler Tyk- og endetarmskræft, Kræft i spiserør og mavesæk, Kræft i bugspytkirtel, Kræft i galdeveje Kolorektale levermetastaser Kræft i hjerne og nervesystem Kræft i øjenæble og øjenhule Lungekræft Metastaser u/ organspecifik kræft DIAGNOSTISK CENTER rt@rn.dk henrik.vorum@rn.dk eller hv@biokemi.au.dk pvm@rn.dk Forløbskoordinatorer Navn mail Trine Worm Kristensen, lægesekretær, Mammakirurgisk Område twk@rn.dk Kathi Haahr Kristensen khk@rn.dk Maiken Harbo Rukjær, lægesekretær, Gyn-obs afd.

https://www.pdf-archive.com/2018/03/07/kraeftpakker-oversigt-over-foloebsledere-og-koordinatorer/

07/03/2018 www.pdf-archive.com

55 (4) 57%

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa.

https://www.pdf-archive.com/2018/01/17/55-4/

17/01/2018 www.pdf-archive.com

ER1054 57%

Page 3 Course Co-Directors Hillard Lazarus, MD Division of Hematology and Oncology University Hospitals Cleveland Medical Center Keith McCrae, MD Department of Hematology/Oncology Cleveland Clinic Guest Faculty Shruti Chaturvedi, MD Department of Medicine Johns Hopkins Hospital Baltimore, MD David Vesole, MD Co-Division Chief, Myeloma Hackensack Meridian Health Hackensack, NJ Cleveland Faculty Dana Angelini, MD Cleveland Clinic Suzanne Bakdash, MD, MPH Cleveland Clinic Paolo Caimi, MD Sudipto Mukheijee, MD Cleveland Clinic Yogen Saunthararajah, MD Cleveland Clinic Alvin Schmaier, MD University Hospitals Cleveland Medical University Hospitals Cleveland Medical Center Center Krista Dobbie, MD Cleveland Clinic Matt Kalaycio, MD Cleveland Clinic Page 4 Agenda January 24,2018 InterContinental Hotel and Conference Center 8:00 Registration 8:30 Welcome BENIGN HEMATOLOGY 8:35 Introduction/ASH Highlights Keith McCrae, MD 8:45 Thrombotic Disorders - Dana Angelini, MD 9:15 Transfusion Medicine - Suzanne Bakdash, MD, MPH 9:45 Platelet Disorders - Shruti Chaturvedi, MD 10:15 Break 10:30 Bleeding Disorders Alvin Schmaier, MD MALIGNANT HEMATOLOGY 11:00 Introduction/ASH Highlights - Hillard Lazarus, MD 11:05 Chronic Myeloid Leukemia - Sudipto Mukherjee, MD 11:40 Lunch 12:15 Healing Hooves:

https://www.pdf-archive.com/2018/07/10/er1054/

10/07/2018 www.pdf-archive.com

ER1031 51%

Inherited myeloid neoplasms Tom Vulliamy (London) 4.

https://www.pdf-archive.com/2018/06/20/er1031/

20/06/2018 www.pdf-archive.com

2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program 49%

Gema Moreno-Bueno, MD Anderson Cancer Center Madrid, Spain 10:45 - 11:15 New insights into myeloid neoplasms Dr.

https://www.pdf-archive.com/2018/06/18/untitled-pdf-document/

18/06/2018 www.pdf-archive.com

Riches CV March 2016 37%

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

https://www.pdf-archive.com/2016/11/15/riches-cv-march-2016/

15/11/2016 www.pdf-archive.com

ASH 2011 Bystander vaccine poster 35%

acute myeloid leukemia. Atanackovic D, et al.

https://www.pdf-archive.com/2011/12/08/ash-2011-bystander-vaccine-poster/

08/12/2011 www.pdf-archive.com

m140000 35%

Elevated numbers of circulating neutrophils have been shown to be predictive of cardiovascular events independent of serum cholesterol levels (Guasti et al, 2011) In a more recent study, a direct mechanistic link between hypercholesterolemia and proliferation of myeloid progenitor cells and, hence, neutrophilia and monocytosis has been identified (Murphy et al, 2011 and Weber et al, 2011).

https://www.pdf-archive.com/2015/07/27/m140000/

27/07/2015 www.pdf-archive.com

art 10.1007 s11481-013-9485-1 26%

Specifically, CD3+ (T-cells) and CD11b+ (myeloid derived cells) populations were selected and individually treated with JWH-015 or ethanol vehicle, or O-1966 or DMSO vehicle, before being added back to the remainder of the untreated spleen cells, which were either CD3 or CD11b depleted, to restore the normal spleen population.

https://www.pdf-archive.com/2015/01/23/art-10-1007-s11481-013-9485-1/

23/01/2015 www.pdf-archive.com